The endogeneous formation of highly chlorinated tetrahydro-beta-carbolines as a possible causative mechanism in idiopathic Parkinson's disease
- PMID: 15206739
- DOI: 10.1007/978-1-4615-0135-0_29
The endogeneous formation of highly chlorinated tetrahydro-beta-carbolines as a possible causative mechanism in idiopathic Parkinson's disease
Abstract
The causative interrelationship between long-term, low level exposure to chlorinated volatile organic solvents (VOSs) and neurodegenerative diseases (polyneuropathy, encephalopathy) are still an issue of controversial debate. Endogeneously formed chlorinated tetrahydro-beta-carbolines found by Bringmann 1995 (TaClo hypothesis) may contribute, in particular, to the development of (idiopathic) Parkinson's disease (PD) in the presence of the sufficient amount of trichloroacetaldehyde, an intermediate in metabolism of trichloroethylene (TRI). Long-term storage of specific VOSs over years, evident frrom exhalation pattern during the postexposure period, may serve as a promoting factor to form continuously TaClo non-enzymatically from tryptamine and trichloroacetaldehyde. Thus, the induction of TaClo-mediated neurotoxic processes extends over years. The onset of Parkinson's disease in three chronic TRI-exposed individuals during the postexposure period could be associated with the presence of TaClo in ng-range. Consequently, determination of TaClo and its derivatives in blood of humans exposed to chlorinated VOSs may serve as a marker of risk indicating either causative or supportive processes of neurodegeneration that may lead to manifestation of PD after many years.
Similar articles
-
The TaClo concept: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a new toxin for dopaminergic neurons.J Neural Transm Suppl. 1995;46:235-44. J Neural Transm Suppl. 1995. PMID: 8821060 Review.
-
Trichloroethylene and Parkinson's Disease: Risk Assessment.Mol Neurobiol. 2018 Jul;55(7):6201-6214. doi: 10.1007/s12035-017-0830-x. Epub 2017 Dec 22. Mol Neurobiol. 2018. PMID: 29270919
-
1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) Alters Cell Cycle Progression in Human Neuroblastoma Cell Lines.Neurotox Res. 2017 Nov;32(4):649-660. doi: 10.1007/s12640-017-9782-1. Epub 2017 Jul 18. Neurotox Res. 2017. PMID: 28721631
-
Studies of the potentially endogenous toxin TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) in neuronal and glial cell cultures.J Neural Transm Suppl. 1995;46:255-63. J Neural Transm Suppl. 1995. PMID: 8821062
-
TaClo as a neurotoxic lead: improved synthesis, stereochemical analysis, and inhibition of the mitochondrial respiratory chain.J Neural Transm Suppl. 1995;46:245-54. J Neural Transm Suppl. 1995. PMID: 8821061 Review.
Cited by
-
Parkinson's Disease Progression and Exposure to Contaminated Water at Camp Lejeune.Mov Disord. 2024 Oct;39(10):1732-1739. doi: 10.1002/mds.29922. Epub 2024 Jul 11. Mov Disord. 2024. PMID: 38988230
-
Low-dose inhalation exposure to trichloroethylene induces dopaminergic neurodegeneration in rodents.Toxicol Sci. 2023 Nov 28;196(2):218-228. doi: 10.1093/toxsci/kfad090. Toxicol Sci. 2023. PMID: 37669148 Free PMC article.
-
The centrality of mitochondria in the pathogenesis and treatment of Parkinson's disease.CNS Neurosci Ther. 2014 Jul;20(7):591-602. doi: 10.1111/cns.12264. Epub 2014 Apr 7. CNS Neurosci Ther. 2014. PMID: 24703487 Free PMC article. Review.
-
Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy Implications.Mov Disord. 2025 Feb;40(2):204-221. doi: 10.1002/mds.30067. Epub 2024 Nov 27. Mov Disord. 2025. PMID: 39601461 Free PMC article. Review.
-
Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence.Toxicol Appl Pharmacol. 2013 Feb 1;266(3):345-55. doi: 10.1016/j.taap.2012.11.016. Epub 2012 Dec 7. Toxicol Appl Pharmacol. 2013. PMID: 23220449 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical